FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Promethazine (Phenergan) Injection
Status: Currently in Shortage
»Date first posted: 03/23/2017
»Therapeutic Categories: Analgesia/Addiction; Gastroenterology; Pediatric; Pulmonary/Allergy

Expand all

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 07/22/2020)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg/mL, 1 mL vial (NDC 0641-0928-25) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Other
50 mg/mL ,1 mL vial (NDC 0641-0929-25) Inventory is currently available Additional lots are scheduled to be manufactured. Product will be made available as it is released. Other
25 mg/mL, 1 mL ampul (NDC 0641-1495-35) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
50 mg/mL, 1 mL ampul (NDC 0641-1496-35) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
PHENERGAN Injection 25 mg/mL, 1 mL vial (NDC 0641-6084-25) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Other
PHENERGAN Injection 50 mg/mL ,1 mL vial (NDC 0641-6085-25) Inventory is currently available Additional lots are scheduled to be manufactured. Product will be made available as it is released. Other
PHENERGAN Injection 25 mg/mL, 1 mL ampul (NDC 0641-6082-25) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
PHENERGAN Injection 50 mg/mL, 1 mL ampul (NDC 0641-6083-25) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug

X-GEN Pharmaceuticals, Inc. (Reverified 12/11/2019)

Company Contact Information:
866-390-4411

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg/mL, Carton of 25 ampuls (NDC 39822-5525-3) Available Demand increase for the drug
50 mg/mL, Carton of 25 ampuls (NDC 39822-5550-6) Available Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English